EFFICIENT HYBRIDIZATION OF MOUSE-HUMAN CELL-LINES BY MEANS OF HYPOOSMOLAR ELECTROFUSION

被引:29
作者
ZIMMERMANN, U
GESSNER, P
SCHNETTLER, R
PERKINS, S
FOUNG, SKH
机构
[1] UNIV WURZBURG, INST BIOTECHNOL, W-8700 WURZBURG, GERMANY
[2] STANFORD UNIV, MED CTR, SCH MED, DEPT PATHOL, STANFORD, CA 94305 USA
关键词
Hybridoma formation; Hypo-osmolar electrofusion; Mouse-human cell line;
D O I
10.1016/0022-1759(90)90110-H
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The fusion of a mouse-human heteromyeloma with a mouse hybridoma is used as a model to define parameters to generate human hybridomas. Electrofusion of these cells in 300 mosM and 75 mosM solutions showed that strong hypo-osmolar conditions resulted in a dramatic increase in the efficiency of hybridoma formation. In contrast to iso-osmolar electrofusion, a high hybrod yield could be obtained by injection of only a single field pulse. The field strength was adjusted in proportion to the increased size of the cells in hypo-osmolar solutions. Hypo-osmolar electrofusion allowed the generation of approximately 0.45% hybrids at a suspension density of 1.75·105 mouse-human cells/ml corresponding to an input number of 3.5·104 mouse-human cells. A further increase in the efficiency of hybridoma formation to about 0.6% was achieved by cell alignment in an alternating field of modulated field strength. Experiments in which the total cell number per fusion chamber was decreased at constant optimum suspension density showed that a further increase in the efficiency of hybridoma formation in hypo-osmolar solution was not possible because of the increasing influence of the heterogeneity of the cell lines with decreasing cell number. The results allow the conclusion that hypo-osmolar electrofusion is a potential tool to enhance succesful immortalisation of human B lymphocytes. © 1990.
引用
收藏
页码:43 / 50
页数:8
相关论文
共 28 条
[1]   OSMOTIC FORCES IN ARTIFICIALLY INDUCED CELL-FUSION [J].
AHKONG, QF ;
LUCY, JA .
BIOCHIMICA ET BIOPHYSICA ACTA, 1986, 858 (01) :206-216
[2]   NUCLEAR-MEMBRANE FUSION IN ELECTROFUSED MAMMALIAN-CELLS [J].
BERTSCHE, U ;
MADER, A ;
ZIMMERMANN, U .
BIOCHIMICA ET BIOPHYSICA ACTA, 1988, 939 (03) :509-522
[3]   HUMAN HYBRIDOMA CELLS PRODUCED BY ELECTRO-FUSION [J].
BISCHOFF, R ;
EISERT, RM ;
SCHEDEL, I ;
VIENKEN, J ;
ZIMMERMAN, U .
FEBS LETTERS, 1982, 147 (01) :64-68
[4]   HIGH YIELDS OF STABLE TRANSFORMANTS BY HYPO-OSMOLAR PLASMID ELECTROINJECTION [J].
DAUMLER, R ;
ZIMMERMANN, U .
JOURNAL OF IMMUNOLOGICAL METHODS, 1989, 122 (02) :203-210
[5]   DEVELOPMENT OF MICROFUSION TECHNIQUES TO GENERATE HUMAN HYBRIDOMAS [J].
FOUNG, S ;
PERKINS, S ;
KAFADAR, K ;
GESSNER, P ;
ZIMMERMANN, U .
JOURNAL OF IMMUNOLOGICAL METHODS, 1990, 134 (01) :35-42
[6]   ELECTRIC FIELD-INDUCED CELL-FUSION AND HUMAN MONOCLONAL-ANTIBODIES [J].
FOUNG, SKH ;
PERKINS, S .
JOURNAL OF IMMUNOLOGICAL METHODS, 1989, 116 (01) :117-122
[7]   HUMAN MONOCLONAL-ANTIBODIES TO HUMAN CYTOMEGALO-VIRUS [J].
FOUNG, SKH ;
PERKINS, S ;
BRADSHAW, P ;
ROWE, J ;
RABIN, LB ;
REYES, GR ;
LENNETTE, ET .
JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (03) :436-443
[8]   CREATING HYBRIDOMAS BY ELECTROFUSION. [J].
Glassy, Mark C. .
Nature, 1988, 333 (6173) :579-580
[9]   EFFORTS TO PRODUCE HUMAN CYTOTOXIC T-CELL HYBRIDOMAS BY ELECTROFUSION AND PEG FUSION [J].
GRAVEKAMP, C ;
SANTOLI, D ;
VREUGDENHIL, R ;
COLLARD, JG ;
BOLHUIS, RLH .
HYBRIDOMA, 1987, 6 (02) :121-133
[10]   HUMAN MONOCLONAL-ANTIBODY PRODUCTION - CURRENT STATUS AND FUTURE-PROSPECTS [J].
JAMES, K ;
BELL, GT .
JOURNAL OF IMMUNOLOGICAL METHODS, 1987, 100 (1-2) :5-40